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Abstract
Oxidative stress results in deleterious cell function in pathologies associated with inflammation. Here, we investigated the
generation of superoxide anion as well as the anti-oxidant defense systems related to the isoforms of superoxide
dismutases (SOD) in cystic fibrosis (CF) cells. Pro-apoptotic agents induced apoptosis in CF but not in control cells that was
reduced by treatment with SOD mimetic. These effects were associated with increased superoxide anion production,
sensitive to the inhibition of IkB-a phosphorylation, in pancreatic but not tracheal CF cells, and reduced upon inhibition of
either mitochondrial complex I or NADPH oxidase. CF cells exhibited reduced expression, but not activity, of both Mn-SOD
and Cu/Zn-SOD when compared to control cells. Although, expression of EC-SOD was similar in normal and CF cells, its
activity was reduced in CF cells. We provide evidence that high levels of oxidative stress are associated with increased
apoptosis in CFTR-mutated cells, the sources being different depending on the cell type. These observations underscore a
reduced anti-oxidant defense mechanism, at least in part, via diminished EC-SOD activity and regulation of Cu/Zn-SOD and
Mn-SOD expressions. These data point to new therapeutic possibilities in targeting anti-oxidant pathways to reduce
oxidative stress and apoptosis in CF cells.
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Introduction
Cystic fibrosis (CF) is the most prevalent inherited and lethal
disease in the caucasian population. It is due to mutations in the
gene encoding the cystic fibrosis transmembrane conductance
regulator (CFTR) protein. Expressed in the majority of epithelial
cells [1], CFTR, an ATP-dependent membrane glycoprotein,
acts as a cAMP-regulated chloride channel [2], and as GSH
transporter, the major anti-oxidant of the cell [3], suggesting that
CFTR might regulate cellular redox status. More than 1,800
mutations have been identified resulting in a defective CFTR
protein [4]. The largely prevalent mutation [i.e., the deletion of
residue Phe-508 (DF508)] leads to a partial functional trafficking
mutant that is capable of conducting chloride, but is prematurely
degraded from the endoplasmic reticulum [5].
Absence of functional channel CFTR at the plasma membrane
does not permit water flux, leading to dehydrated secretion in all
tracts, notably airway and pancreatic tracts [6–8], and impaired
secretion clearance. Obstruction of tracts results in epithelial
destruction and favors the proliferation of bacteria in airways. CF
is characterized by chronic inflammation even in absence of
pathogens, and by the recruitment of activated neutrophils. The
origin of pro-inflammatory mediator production remains obscure
and appears to be the consequence of hyperactivation of NF-kB
transcription factor and the CFTRDF508 retention into endo-
plasmic reticulum (for review see [9]).
Under pathophysiological conditions, activated neutrophils and
epithelial cells release highly reactive molecules towards the
extracellular space, like reactive oxygen species (ROS) and reactive
nitrogen species in order to attack and eliminate invasive
pathogens [10,11]. However, in CF, several evidences show that
the defense systems are ineffective. Indeed, mitochondrial levels of
ROS are enhanced in CFTR2/2 lung epithelial cell line [12]
suggesting that, in CF, an increased production of ROS may be
associated with cell dysfunction and the incidence of disease.
Conversely, in CF airways, levels of nitric oxide (NO) have been
described to be low [13] and are associated with a reduction of
inducible NO synthase activity [14,15] that could favor bacterial
infection [16].
In addition to excessive oxidative and nitrosative stresses,
defective neutralization of ROS can also exacerbate noxious
functions in CF. Superoxide anion (O2
2) is dismutated into
oxygen and hydrogen peroxide by superoxide dismutase (SOD),
an endogenous cellular defense system, which decreases O2
2 levels
that damage cells at excessive concentration [17]. Extracellular-
SOD (EC-SOD, SOD 3), Mn-SOD (SOD 2) and Cu/Zn-SOD
(SOD 1) have been described as potent inhibitors of inflammation
[18,19]. Although no direct evidence has shown the involvement
of deregulation of SODs in CF, the fact that EC-SOD is highly
expressed in airways and up-regulated in animal models of lung
injury [20], it raises the possibility that SODs, and EC-SOD in
particular, may play a role in CF. We have previously reported
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activation, both contributing to the self-perpetuating inflammatory
cycle [21]. In the present study, we investigated the involvement of
oxidative stresses in the apoptotic response of CF pancreatic and
tracheal cells. For this, we used two pancreatic and tracheal cell
lines expressing the wild-type CFTR (PANC-1 and NT-1,
respectively) or CFTRDF508 protein (CFPAC-1 and CFT-2,
respectively). Firstly, we investigated whether oxidative stress is
implicated in the exacerbated apoptotic response of CF cells using
a SOD mimetic and analyzing O2
2 production. Furthermore, we
examined the origin of ROS production. Secondly, analysis of
SOD expressions and activities were performed.
Methods
Reagents
Cell culture reagents, Hank’s balanced salt solution (HBSS), and
trypsin/EDTA were obtained from Lonza (Verviers, Belgium).
Fetal calf serum (FCS) was obtained from Invitrogen (Cergy-
Pontoise, France). Actinomycin D (Act D), staurosporine (St),
propidium iodide (PI), type I-A RNase A, rotenone, allopurinol,
apocynin, and antibody to b-actin were purchased from Sigma-
Aldrich (St. Louis, MO). The SOD mimetic, manganese (III)
tetrakis (1-methyl-4-pyridyl) porphyrin pentachloride (MnTMPyP)
was obtained from Calbiochem (Nottingham, UK). Ripa lysis
buffer was provided from Upstate Biotech (Hampshire, UK).
Inhibitor of IkB-a phosphorylation (Bay 11-7082) was purchased
from BioMol Research Labs, Inc. (Exeter, UK).
Cell culture and induction of apoptosis
The pancreatic cancer cell line PANC-1 expressing endogenous
CFTR and CFPAC-1, presenting the CFTRDF508 mutation,
were purchased from the American Type Culture Collection
(Rockville, MD). PANC-1 is a human epithelioid pancreas
carcinoma cell line and was grown in DMEM. CFPAC-1 is a
human pancreatic adenocarcinoma cell line and was grown in
IMDM. The tracheal cell line NT-1, derived from non-CF human
fetus, and the CFT-2 cell line, homozygous for the DF508
mutation, were a kind gift from Dr. M. Mergey (UMR S893
INSERM, Paris, France) and were grown in DMEM/F12 (1:1)
[21]. All media were supplemented with 10% heat-inactivated
FCS, 100 mg/ml streptomycin, and 100 U/ml penicillin. CFPAC-
1, NT-1, and CFT-2 cells were incubated in humidified 5% CO2
atmosphere at 37uC. PANC-1 cells were cultured at 37uCi na
humidified atmosphere of 7.5% CO2, as recommended by the
American Type Culture Collection. Cell viability was checked by
Trypan blue exclusion. Cells were seeded at 7.5610
4 cells in T75
flasks. All experiments were carried out when the cells were 80–
90% confluent. They were incubated in the presence or absence of
Act D (0.5 mg/ml), St (0.33 nM), MnTMPyP (50 mM), Bay 11-
7082 (Bay, 7.5 mM), rotenone (5 mM), apocynin (100 mM) or
allopurinol (50 mM) for 24 h. All agents were used at concentra-
tions at which no cytotoxicity was observed, as deduced from
Trypan blue exclusion.
Superoxide anion (O2-) determination by electronic
paramagnetic resonance (EPR)
After 24 h of apoptosis treatment, cell medium was replaced
with deferoxamine-chelated Krebs-Hepes solution containing 1-
hydroxy-3-methoxycarbonyl-2,5,5-tetramethylpyrrolidin (CMH;
Noxygen, Mainz, Germany) (500 mM), deferoxamine (25 mM),
and diethyldithio carbamate (5 mM) under constant temperature
(37uC) for 30 minutes. Cells when then scrapped and frozen in
plastic tubes and analyzed in a Dewar flask by EPR spectroscopy
using a table-top x-band spectrometer Miniscope (MS200;
Magnettech, Berlin, Germany), as previously described [22].
Values are expressed as amplitude of signal per protein
concentration.
Determination of hypodiploid DNA
After treatments, culture medium was removed from cells
growing in monolayers; adherent cells were trypsinized, detached,
combined with floating cells from the original culture medium,
and centrifuged. Cells were then fixed in 70% ethanol for at least
4 h at 4uC and washed once in 1 mM HBSS Ca
2+ before
resuspension for 10 min in a solution containing type I-A RNase A
(0.05 mg/ml) in HBSS containing 1 mM Ca
2+ at 37uC. PI was
then added at a final concentration of 0.1 mg/ml, as previously
described [21]. After 15 min in the dark at room temperature,
samples were analyzed by flow cytometry using a FACScan flow
cytometer (Becton Dickinson, San Jose, CA). Data acquisition
(10,000 events in each case) and analysis were conducted using
CELLQuest software (Becton Dickinson). The forward light
scatter setting was E-01.
Western blot analysis
After incubation with apoptosis-inducing agents for 24 h, cells
were scrapped in the presence of 400 ml of Ripa buffer with
10 mg/ml leupeptin, 10 mg/ml pepstatin, 10 mg/ml aprotinin, and
1 mM phenylmethanesulfonylfluoride. Samples containing 20 mg
proteins (Bio-Rad protein assay kit) were separated on 10% SDS-
PAGE. Separated proteins were then blotted onto Hybond-ECL
nitrocellulose membrane (Amersham Biosciences, Buckingham-
shire, UK). Blots were probed with antibodies against Mn-SOD,
Cu/Zn-SOD and EC-SOD (Stressgen, MI), and developed with
horseradish peroxidase-conjugated secondary antibody. Bound
antibodies were revealed by chemiluminescence (Pierce, Rockford,
IL); ß-actin staining was used as control. Enzyme levels were
determined by densitometry analysis and were normalized with
respect to ß-actin.
Determination of SOD activities
Analysis of SOD activities were performed according to the
manufacturer’s instructions (Stressgen, MI). Briefly, cells were
cultured in the absence or in the presence of Act D (0.5 mg/ml) or
St (0.33 nM), and after 24 h, cells were washed, detached with
trypsin and washed with ice cold phosphate buffer saline. EC-
SOD activity measurement was performed using culture superna-
tant and Cu/Zn-SOD and Mn-SOD using cell lysate. Also, Cu/
Zn-SOD was isolated by adding ice-cold chloroform/ethanol
(37.5/62.5 (v/v)) and its activity measured. Absorbance was read
at 405 nm for 10 min at room temperature. Data were expressed
as mg of protein/ml.
Statistical analysis
Data are represented as mean 6 SEM; n represents the number
of experiments. Statistical analysis was carried out using Student’s t
test or non-parametric Mann-Whitney U test. Differences were
considered statistically significant at a value of p,0.05.
Results
The SOD mimetic reduces the increased sensitivity to
apoptogenic agents in cells with CFTR dysfunction
Pancreatic and tracheal cells were incubated in the absence and
in the presence of the SOD mimetic MnTMPyP (50 mM), 30 min
before treatment with pro-apoptotic agents for 24 h. Staining with
Reduced Anti-Oxidant Defenses in Cystic Fibrosis
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corresponding to apoptotic cells, measured by flow cytometry.
As previously described [21], CF cells displayed exacerbated
apoptosis in the presence of Act D or St (Fig. 1, A and B). Higher
concentrations of apoptotic agents did not induce further increase
of apoptosis, but an enhanced necrosis was observed (near of
60%). MnTMPyP treatment had no effect on basal apoptosis
which was not significantly different between normal cells or cells
with CFTR dysfunction (Fig. 1, A and B). Interestingly,
MnTMPyP was able to decrease Act D- and St-induced apoptosis
in CF cells. Indeed, MnTMPyP decreased hypodiploid DNA
content by 29% and 58% in Act D- and St-treated CF pancreatic
cells, respectively (Fig. 1A). Similar results were obtained in
tracheal cells, MnTMPyP inhibited apoptosis by 62% and 73% in
Act D- and St-treated CFT-2 cells, respectively (Fig. 1B). These
results suggest that oxidative stress is involved in the induction of
apoptosis in CF cells.
O2
2 production in normal and CF cells
All types of cells exhibited an EPR feature of signals derived
from CMH-O2
2 complex. Measurement of O2
2 production
shows that, in pancreatic and tracheal normal cells, apoptotic
treatment did not induce significant changes in O2
2 levels (Fig. 2,
A and B). By contrast, Act D- or St-treated CF cells displayed an
increase of O2
2 levels (Fig. 2, A and B). Treatment with the SOD
mimetic MnTMPyP abolished the increase in O2
2 levels evoked
by Act D or St in CF cells (Fig. 2, A and B). To determine the
sources of O2
2 production involved in the induction of apoptosis
in CF cells, both pancreatic and tracheal CF cells were incubated
in the presence of inhibitors of xanthine oxidase (allopurinol),
NADPH oxidase (apocynin) or mitochondrial complex I (rote-
none), and Act D-induced apoptosis was evaluated. Apoptosis
induction was independent of xanthine oxidase in both pancreatic
and tracheal cells. In contrast, rotenone reduced apoptosis in
pancreatic CF cells and apocynin in tracheal CF cells (Table 1).
Because, in CF cells, NF-kB pathway is activated under basal as
well as apoptotic conditions [21], we have investigated the effects
of inhibition of IkB-a phosphorylation on O2
2 production, using
Bay 11-7082. Interestingly, when Ik-Ba phosphorylation was
inhibited in pancreatic CF cells, basal O2
2 production was not
modified but the increase in O2
2 generation induced by apoptotic
agents was reduced (Fig. 2A). Surprisingly, in tracheal CF cells,
inhibition of Ik-Ba phosphorylation induced a strong increase in
O2
2 production and blunted the response evoked by apoptotic
treatment (Fig. 2B).
Expression of SOD in normal and CF cells
As shown in Fig. 3A–D, expression of both Cu/Zn-SOD and
Mn-SOD was down-regulated in CF cells. On the one hand, pro-
apoptotic stimuli significantly decreased Cu/Zn-SOD expression
in normal pancreatic cells (PANC-1) but not in normal tracheal
cells (NT-1). On the other hand, pro-apoptotic stimuli increased
Mn-SOD expression in NT-1 cells but not in PANC-1. Of note
was that pro-apoptotic stimuli had no effect on either Cu/Zn-
SOD or Mn-SOD in CF cells. Concerning EC-SOD, no
difference in expression was observed in both normal and CF
cells (Fig. 3, E and F). In addition, pro-apoptotic treatment had no
effect on EC-SOD expression.
SOD activity in normal and CF cells
Activities of intracellular SODs (Cu/Zn-SOD and Mn-SOD)
and EC-SOD were measured in pancreatic and tracheal cells
(Fig. 4). No differences were observed in Cu/Zn-SOD and Mn-
SOD activities between normal and CF cells. Interestingly, activity
of EC-SOD was lower in CF cells than in normal cells. Pro-
apoptotic treatments did not modify SOD activities.
Discussion
It has been suggested that excessive ROS production accounts
for a variety of the degenerative processes of some human diseases
due to their deleterious effect to target cells [11,23,24]. The data
reported here show that increased susceptibility of apoptosis of
pancreatic and tracheal CF cells is associated with enhanced ROS
Figure 1. The SOD mimetic MnTMPyP reduces the increased
sensitivity to apoptogenic agents of cells with CFTR dysfunc-
tion. (A) At confluence, PANC-1 (n=6, black bars) and CFPAC-1 (n=6,
open bars) and (B) NT-1 (n=6, dark gray bars) and CFT-2 (n=6, light
gray bars) cells were treated with MnTMPyP (Mn) for 30 min before
treatment with actinomycin D (Act D) or staurosporine (St) for 24 h, or
without any treatment (CTL). Cells were permeabilized with 70%
ethanol and hypodiploid DNA was quantified by the use of propidium
iodide. * p,0.05, *** p,0.001 significantly different from respective
control cells; { p,0.05 significantly different between in the absence
and in the presence of Mn.
doi:10.1371/journal.pone.0024880.g001
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inhibition of NF-kB pathway strongly reduced O2
2 production in
CF pancreatic cells suggesting a key role of this pathway in the
regulation of oxidativestress.Furthermore,expression of anti-oxidant
defense enzymes, Cu/Zn-SOD and Mn-SOD, was down-regulated
in CF cells whereas their activities were not affected by CFTR
mutation or by apoptotic treatment. In addition, EC-SOD activity,
but not its expression, was reduced in CF cells when compared to
normal cells. Altogether, these results suggest that disruption of the
balance between ROS generation via NF-kBi n h i b i t o r - s e n s i t i v e
pathway and anti-oxidant defense may account for the sustained
apoptosis and pro-inflammatory profile observed in CF cells.
We have previously shown that both Act D and St induced
apoptosis but not necrosis in CF cells as demonstrated by double
staining Annexin V/propidium iodide and TUNEL assays [21]. In
addition, no apoptosis was observed in control cells under the
same experimental conditions. This was not due to a delayed
apoptotic response, since hypodiploid DNA was measured in all
types of cells after 12 h, 24 h, and 48 h of apoptosis stimulation
and DNA fragmentation was higher in CF cells than in control
cells [21]. In addition, new experiments performed in control cells
using a higher concentration of apoptotic agents showed no
increase of apoptosis, but an enhanced necrosis (near of 60%).
ROS are important mediators of apoptosis mainly in vascular
and epithelial cells, which subsequently initiate a series of local
chemical reactions and genetic alterations resulting in an
amplification of the initial ROS-mediated tissue damage and/or
cytotoxicity [25]. It is estimated that normal levels of ROS are
Figure 2. Superoxide anion production by pancreatic and tracheal cell lines after pro-apoptotic treatments. (A) At confluence, PANC-1
(n=5, black bars) and CFPAC-1 (n=5, open bars), and (B) NT-1 (n=5, dark gray bars) and CFT-2 (n=5, light gray bars) cells were treated with the SOD
mimetic MnTMPyP (Mn) for 30 min or with the inhibitor of phosphorylation of IkB-a, Bay-11702 (Bay) for 30 min before treatment with actinomycin D
(ActD) or staurosporine (St) for 24 h, or without any treatment (CTL). Then, cells were incubated in the presence of superoxide anion spin trap and
quantification of the amplitude of the superoxide anion-CMH complex signal was performed by electronic paramagnetic resonance. Values are
expressed as units per protein concentration (mg/ml). * p,0.05, ** p,0.01 significantly different from respective control cells; {{ p,0.01 significantly
different from in the absence of Bay. NS=not significant.
doi:10.1371/journal.pone.0024880.g002
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such as SOD [26]. However, under conditions associated with
excessive ROS production, the rate of ROS generated can exceed
the capacity of anti-oxidant defense mechanisms to scavenge ROS
and prevent deleterious ROS-evoked reactions. Concerning CF, it
has been shown that endogenous ROS and lipid peroxidation
levels are higher in CFTR2/2 lung when compared to wild-type
(CFTR+/+) in basal conditions, despite a strong enzymatic
antioxidant expression involving SOD, indicating a constitutive
redox imbalance [27]. Also, increased oxidative stress is respon-
sible to defective autophagy in CF cells resulting in the
accumulation of misfolded mutant CFTR protein [28]. Here, we
provide evidence that O2
2 mediated exacerbated apoptosis in CF
cells since SOD mimetic, MnTMPyP, was able to reduce
apoptosis induced by Act D and St. It has been reported that, in
hepatocytes, oxidative stress induced by O2
2 activates caspases
Table 1. Effects of inhibition of NADPH oxidase by apocynin,
xanthine oxidase by allopurinol and mitochondrial complex I
by rotenone on actinomycin D-induced apoptosis in pancreatic
(CFPAC-1) and tracheal (CFT-2) cystic fibrosis cells (n=5).
CFPAC-1 CFT-2
Actinomycin D
Apocynin 0.460.6% 1460.02%*
Allopurinol 4.160.4% 1160.1%
Rotenone 1260.5%* 1.160.4%
Data are expressed in percentage of inhibition of actinomycin D-induced
apoptosis.
*p,0.05.
doi:10.1371/journal.pone.0024880.t001
Figure 3. Expression of SOD in pancreatic and tracheal cells. At confluence, PANC-1 (n=5, black bars) and CFPAC-1 (n=5, open bars), NT-1
(n=5, dark gray bars) and CFT-2 (n=5, light gray bars) cells were treated with actinomycin D (Act D) or staurosporine (St) for 24 h, or without any
treatment (CTL). Five determinations yielding similar results were performed. A b-actin control was included. Western-Blot were performed for Cu/Zn-
SOD (A, B), for Mn-SOD (C, D) and for EC-SOD (E, F). SOD expressions were quantified by densitometric analysis and measurements were normalized
with respect to b-actin. Densitometry values are given as mean 6 SEM * p,0.05 significantly different from respective control cells; { p,0.05, {{
p,0.01 significantly different between both types of cells.
doi:10.1371/journal.pone.0024880.g003
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ment of the Bcl-2 family proteins [29]. Regarding the source of
O2
2, whereas mitochondria seem to play a role in pancreatic CF
cells, inhibition of NADPH oxidase with apocynin reduced
apoptosis in tracheal CF cells indicating the implication of
NADPH oxidase. These results are in accordance with those
showing that the main source of O2
2 in pancreatic and tracheal
cells is mitochondria and NADPH oxidase, respectively. Thus, in
pancreatic cells, mitochondrial complex I and III are involved in
ROS generation leading to apoptosis induction [30]. In tracheal
epithelial and smooth muscle cells, the increase of O2
2 production
via the activation of NADPH oxidase may exacerbate pulmonary
inflammation [31,32]. However, we cannot exclude that other
sources of O2
2 might be implicated in the mechanisms leading to
apoptosis in CF cells. Indeed, inhibition of complex I with
rotenone reduced Act D-induced apoptosis of pancreatic CF cells
about ,12% whereas the SOD mimetic reduced it ,30%. Similar
results were observed in tracheal CF cells. These results suggest
that probably other sources of O2
2 are involved in the induction
of apoptosis in CF cells.
Interestingly, (i) basal O2
2 production was similar in all cell
types, (ii) apoptotic treatment did not modify O2
2 production in
normal cells, (iii) in CF cells, apoptotic treatment enhanced O2
2
production, (iv) inhibition of NF-kB pathway reduced apoptosis-
induced O2
2 production in pancreatic CF cells, and (v) in tracheal
CF cells, the NF-kB pathway seems to regulate basal production of
O2
2. We have previously shown that NF-kB pathway controls
apoptosis and inflammation in CF cells [21]. Altogether these
results indicate that NF-kB pathway, in part via stimulation of
oxidative stress, plays an important role in mediating both
apoptosis and inflammation in CF cells. Unexpectedly, inhibition
of NF-kB pathway, in the absence of apoptosis inducers, elicited a
strong increase on O2
2 production only in tracheal CF cells,
suggesting a beneficial role for NF-kB activation in tracheal, but
not pancreatic, CF cells. It is possible that differences in the
regulation of basal O2
2 production by NF-kB are related to the
different profile of pro-inflammatroy secretome of both types of
cells [21] or the regulation of NADPH oxidase activity by the NF-
kB pathway [32,33]. Under these conditions, apoptotic stimuli
failed to further enhance O2
2 production, probably because the
system was already exhausted upon blockade of NF-kB pathway.
This also strengthens the hypothesis that an exacerbated negative
control of O2
2 production via NF-kB pathway under normal
conditions. Indeed, dual effects of NF-kB by exerting either
protective or deleterious effect have been reported depending on
the conditions [34].
EC-SOD is highly expressed in airways and up-regulated in
animal models of lung injury [20]. These results raise the
possibility that SODs may play a role in CF. This hypothesis
was further assessed by looking at both expressions and activities of
Figure 4. Activity of SODs in pancreatic and tracheal cells. At confluence, PANC-1 (n=5, black bars) and CFPAC-1 (n=5, open bars), NT-1
(n=5, dark gray bars) and CFT-2 (n=5, light gray bars) cells were treated with actinomycin D (Act D) or staurosporine (St) for 24 h, or without any
treatment (CTL). Activity of both Cu/Zn-SOD and Mn-SOD are measured in A and B, and activity of EC-SOD in C and D. Enzymatic activity is expressed
in absorbance units (A) per total protein concentration (mg/ml). { p,0.05, {{ p,0.01, {{{ p,0.001 significantly different between both types of cells.
doi:10.1371/journal.pone.0024880.g004
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SOD isoforms was reduced in CF cells when compared to normal
cells even though their activities were not modified. The fact that
apoptotic treatments exerted differential effects on the two
isoforms in the normal but not in CF cells suggests that these
stimuli might not play a major role in controlling the expression of
these enzymes in CF. By contrast, EC-SOD expression was not
modified but its activity was reduced in CF cells. Thus, although
an insufficient expression of SODs could account for an increased
level of O2
2, it is most likely that the reduction in EC-SOD
activity plays an essential role in the elevation on O2
2 levels. In
agreement with the present results, Madarasi et al. [35] have
shown that in plasma from patients with CF, SOD activities were
significantly lower when compared with healthy subjects. Also,
reduced activity of Cu/Zn-SOD has been described in mononu-
clear, polymorphonuclear and red cells in CF patients [36,37].
Although EC-SOD has not been studied in CF, it has been shown
that EC-SOD overexpression attenuates endotoxin-induced acute
lung injury [38] and EC-SOD knock-out mice are more sensitive
to pulmonary inflammation than wild type mice [39] suggesting
that EC-SOD limits injury in response to many pulmonary insults.
Altogether, these results suggest a reduced anti-oxidant defense
mechanism in CF cells, at least in part, via diminished EC-SOD
activity.
In conclusion, we provide evidence that, in CFTR mutated
cells, the link between increased apoptosis and NF-kB activation
associated with inflammation results in high levels of oxidative
stress (Fig. 5). These observations further underscore a reduced
anti-oxidant defense mechanism at least in part via diminished
EC-SOD activity and subtle regulation of Cu/Zn-SOD and Mn-
SOD expression and activities. These data point to new
therapeutic possibilities targeting anti-oxidant pathways to reduce
oxidative stress and apoptosis in CF cells, and thus to limit pro-
inflammatory response in this pathology.
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